XBiotech Inc (XBIT) is a Healthcare · Biotechnology company listed on NASDAQ. Price $2.20 (+0.92%), Market cap $0.08B, 52-week low–high $2.12 ~ $3.50.
XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.
Financial statements, price targets, institutional (13F) holdings and related news for XBiotech Inc are updated in real time on BlackAll Trade.
XBiotech Inc trades at $2.20 (+0.92%). Real-time quotes and charts are available on BlackAll Trade.
XBiotech Inc has a market cap of about $0.08B.
XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory